profile

Floris from Blossom

I write about the science and implementation of psychedelics as medicines. Join to learn alongside me and make the future happen sooner!

PostsLinks
Featured Post

The Bloom 148 - Trauma Under Psychedelics

The Bloom #148 Free Edition rolling Over the last week, it seems that psychedelic research is coming at us faster than ever before. Researchers re-analysed data from a single-blind study of psilocybin-assisted therapy for depression and found that psychological flexibility, mindfulness, and living according to one’s values improved, even four months after the study's conclusion. Next to academic research, I'm seeing an uptick in publications from the psychedelic drug developers, including a...

3 days ago • 2 min read

The Bloom #147 Free Edition the EMA workshop Editor note: My apologies for not getting this email to you last week, I see that it accidentally was stuck in draft - so you are getting this email and the one for this week just a few minutes apart How do psychedelics work? Some may say we have all the answers already, and that all the research currently happening is just an exercise in writing down wisdom that's already present in the wider world outside of academia. Others, notably the...

3 days ago • 3 min read

The Bloom #146 Free Edition open design The psychedelic conference season is just around the corner. I've just updated our Events page, which should now give a good overview of a variety of conferences that are happening in the coming 1.5 years. In-person conferences include ICPR, which has just added a policy-focused day (Pathways of Access Summit) at the start of the conference; with the code BLOSSOM50, you can get a €50 discount. Online you can also bump into me at the Psychedelics and...

19 days ago • 3 min read

GROW with FLO by FLO Coaching Spring! A time for action Welcome to GROW with FLO, a newsletter exploring the transformative potential of psychedelic coaching to help you navigate your own journey of growth and self-discovery. Spring has sprung, and with it comes a fresh burst of energy and excitement! Lotte and I are thrilled to bring you the latest updates from FLO Coaching, where we're dedicated to guiding individuals through transformative psychedelic experiences. In this newsletter, we'll...

26 days ago • 3 min read

GROW with FLO door FLO Coaching Lente! Een tijd voor actie Welkom bij GROW with FLO, een nieuwsbrief waarin het transformerende potentieel van psychedelische coaching wordt onderzocht om je te helpen je eigen reis van groei en zelfontdekking te navigeren. De lente is begonnen en daarmee gepaard gaat een nieuwe uitbarsting van energie en opwinding! Floris en ik zijn blij om je de laatste updates te kunnen brengen van FLO Coaching, waar we toegewijd zijn aan het begeleiden van individuen door...

26 days ago • 3 min read

The Bloom #145 Free Edition catching up Welcome to all the new readers of The Bloom. This newsletter usually goes out every week, but due to several circumstances it's only hitting your inbox now. This means there is a lot to cover, and instead of the top 3 articles from last week, I've featured 8. Outside of the lab, two more psychedelic companies have received FDA Breakthrough Designation (a fast-track for review, like the one Lykos is currently in the final stages of). Cybin is developing...

30 days ago • 6 min read

The Bloom #144 Free Edition increasing access Innovation and exploration continue to be the cornerstones of our journey at Blossom. This month, I'm thrilled to unveil a new way in which you can interact with our ever-expanding database of psychedelic research. Imagine a chat interface that not only understands your inquiries but is also backed by the full depth of our research database. This is not a distant dream but a reality we're alpha-testing right now. Discover the future of research...

about 2 months ago • 3 min read

The Bloom #143 Free Edition Unus pro Omnibus, Omnes pro Uno What can we learn from 10 years of PAT in a legal and reimbursed setting? Over 1000 patients have been treated in Switzerland since 2014, though challenges remain in the execution of PAT. One challenge is the question of whether we need to have repeated dosings. For clinical trials, it's standard to ... well ... standardize. But an innovative trial in Canada has studied the effects of doing repeated doses in some participants and...

2 months ago • 4 min read

The Bloom #142 Free Edition PsyPal, not PayPal The FDA has received Lykos' (MAPS PBC) application and has given it priority review. This means a decision can be expected as soon as August this year. In the meantime, several research articles investigated the effects of MDMA in two very different settings. The first looked at the impact of recreational use of MDMA, showing that intention predicted long-term positive outcomes (not setting). The second study compared methylone against MDMA in...

2 months ago • 4 min read

The Bloom #141 Free Edition PsyPal, not PayPal You blink twice, and it's February. The past January brought great news for us Europeans, marking the launch of the PsyPal trial, a research effort spanning nine countries and funded up to the tune of €6.5 million. The research, investigating psilocybin-AT for end-of-life anxiety/depression is the first to do so outside of the scope of cancer. The funding, coming from Horizon Europe, will allow over 100 participants to join the study. Speaking of...

3 months ago • 3 min read
Share this page